Followers | 435 |
Posts | 57599 |
Boards Moderated | 5 |
Alias Born | 01/09/2007 |
Sunday, August 10, 2014 4:11:22 PM
was $to camouflage last weeks re: reg sho %s
hmmmm
note to self: PTOI volume avgs
(4.2014)
Volume (10 day Average) 54,090
Volume (90 day Average) 205,967
(8.2014)
Volume (10 day Average) 54,805
Volume (90 day Average) 68,937
*volume* since Pubco (2009)
Volume (approx) Totals since first publicly traded .. (rounded up/down)
2009 = 7M
2010 = 20M
2011 = 37M
2012 = 31M
2013 = 37M
2014 = 23M (thru eo July)
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=101097998
then ponder a very *conservative* >> query of mine
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=103331903
note to self: *street/underwriters* valued KiOR's IPO @ 15.00
in June 2011 .. *cycle* to 20.00+ b4 *cycling* back down
one could argue that that co.s mgmt team didn't execute
regardless it was worth noting for those analysts on the CCs'
(firms represented and ?s asked of mgmt)
i stand by my years re: comments re: PTOI's *cover* (not to be
confused re: mkt cap) >> if mgmt executes as i anticipate
i see the *entity* with 4+ years of *manipulation* in play
being *lucky* to partially cover in the 20.00 to 40.00 *range*
hence my ongoing comments re: how stock is handled
MM Monthly >> worth noting for *obvious* and those *decoys* utilized
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=104882563
imo >> the amount of money in play re: PTOI is staggering
imo >> $successful early adopter re: this emerging and disruptive technology
$creates generational wealth
and imo *everyone* >> including the dolts and *entity* active
re: OTC stock manipulation for years >> knows it
4kids
all jmo
10/5/07 -- there are no coincidences here ...
oh and like many other longs .. not selling at this level --
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM